Product Data
As a dietary supplement where calcium intake may be inadequate: during childhood, adolescence, pregnancy, lactation, in postmenopausal women and the aged.
In the treatment of calcium deficiency state which may occur in diseases such as hypoparathyroidism (acute and chronic); pseudohypoparathyroidism, postmenopausal and senile osteoporosis, rickets and osteomalacia.
In mild hypercalciuria (exceeding 300 mg /24 hours) as well as in chronic renal failure, or where there is evidence of stone formation in the urinary tract, adequate checks must be kept on urinary calcium excretion. If necessary, dosage should be reduced or calcium therapy discontinued.
High vitamin D intake should be avoided during calcium therapy unless especially indicated.
Certain dietary substances interfere with the absorption of calcium. These include oxalic acid (found in large quantities in rhubarb and spinach), phytic acid (bran and whole cereals) and phosphorus (milk and other dairy products).
Administration of corticosteroids may interfere with calcium absorption.
Calcium compounds reduce blood concentrations of oral tetracyclines.
Concomitant use should be avoided or doses of the drugs should not be taken within 3 hours of each other.